Nausea and vomiting in fractionated radiotherapy: A prospective on-demand trial of tropisetron rescue for non-responders to metoclopramide
- 30 September 1995
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (9), 1461-1464
- https://doi.org/10.1016/0959-8049(95)00208-z
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Anti-emetic efficacy & tolerability of tropisetron in patients (PTS) conditioned with high dose chemoradiotherapy (HDC) pre-bone marrow transplantation (BMT)European Journal Of Cancer, 1993
- Tropisetron, a new 5-HT3 receptor antagonist, in the prevention of radiation-induced emesisRadiotherapy and Oncology, 1992
- The Effect of Ondansetron on Radiation-Induced Emesis and DiarrhoeaActa Oncologica, 1992
- The current role of anti-emetic drugs in oncology: a recent revolution in patient symptom controlCancer Treatment Reviews, 1991
- Comparison of the 5-Hydroxytryptamine3(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced EmesisNew England Journal of Medicine, 1990
- Results of a randomized, double-blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiationClinical Oncology, 1990
- An initial evaluation of Nabilone in the control of radiotherapy-induced nausea and vomitingClinical Radiology, 1984